Nothing Special   »   [go: up one dir, main page]

Simonetti et al., 2016 - Google Patents

Declining mortality among hospitalized patients with community-acquired pneumonia

Simonetti et al., 2016

View HTML
Document ID
9174453107703805346
Author
Simonetti A
Garcia-Vidal C
Viasus D
García-Somoza D
Dorca J
Gudiol F
Carratalà J
Publication year
Publication venue
Clinical Microbiology and Infection

External Links

Snippet

Little information is available on the changes over time in community-acquired pneumonia (CAP) management and their impact on 30-day mortality in hospitalized patients. We performed a prospective, observational study of non-severely immunosuppressed …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Simonetti et al. Declining mortality among hospitalized patients with community-acquired pneumonia
Garcia-Vidal et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors
Hayashi et al. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study
Woodhead et al. Guidelines for the management of adult lower respiratory tract infections
Molinos et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease
Fraser et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay
Garcia-Vidal et al. Aetiology of, and risk factors for, recurrent community-acquired pneumonia
Woodhead et al. Guidelines for the management of adult lower respiratory tract infections‐Full version
Mylotte Nursing home-acquired pneumonia
Gómez-Junyent et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Garcia-Vidal et al. Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis
Maruyama et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly
Mykietiuk et al. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia
Asadi et al. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia
Thomsen et al. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G
Simonetti et al. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia
Fuller et al. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management
Ellison III et al. Acute pneumonia
Lieberman et al. Community-acquired pneumonia in the elderly: a practical guide to treatment
Gacouin et al. Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU)
Sunjaya et al. Prevalence and predictors of third-generation cephalosporin resistance in the empirical treatment of spontaneous bacterial peritonitis
Corrêa et al. Brazilian guidelines for community-acquired pneumonia in immunocompetent adults-2009
Ishida et al. Clinical characteristics of pneumonia in bedridden patients receiving home care: a 3-year prospective observational study
Bedos et al. Host–pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study
Ishida et al. Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance